Inovio Pharmaceuticals Inc. Stock Advances 16.9%, Outperforms Peers
Dow Jones2026/08/13 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. surged 16.9% to $0.90 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.8% to 26,803.03 and the Dow Jones Industrial Average rising 0.1% to 53,839.99.
This was the stock's fourth consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 69.8% short of its 52-week high of $2.98, which the company reached on September 9th.
The stock outperformed some of its peers, as Johnson & Johnson rose 0.5% to $262.08, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.86% to $26.80.
Trading volume totaled 12.6 million, compared to the 50-day average of 2.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 13, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-IIFL Finance rallies to a two-month high, boosted by Blackstone deal
The “outlier” in the AI capital expenditure frenzy: Apple (AAPL.US) keeps spending flat, accounting for less than 5% of sales
Apple continues to stand out among major tech peers, largely avoiding the aggressive wave of capital expenditure associated with artificial intelligence (AI) infrastructure.
Youth Employment Declines for 48 Consecutive Months: Behind the Semiconductor Boom, Young South Koreans Are Being Left Behind by the Times
In South Korea, the unemployment rate in October fell to a three-year low of 2.5%. However, the number of employed people decreased by 50,000, youth employment has declined for 48 consecutive months, and domestic demand remains weak.
Crypto prices
More
